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4.5-year results of  a prospective cohort study on disease course of  primary Dupuytren disease
ABSTRACT
Background
The exact natural course of  Dupuytren disease is unclear. The primary aim of  this 
study was to determine the long-term course of  Dupuytren disease, in patients with 
different disease stages. A secondary aim was to identify factors that are associated 
with disease progression.
Methods
258 Dupuytren disease patients were included in this longitudinal cohort study. 
The follow-up period was 4.5 years, and measurements took place with a 6 months 
interval. In total, 16,340 observations were gathered. Disease extent (surface area) 
and contracture severity (TPED) were measured by physical examination, and 
demographic details were registered. Additionally, information on lifestyle factors, 
related diseases, and exposure to heavy manual work was gathered.
Subject-specific mixed-effects models were used to estimate the natural disease 
course in both outcomes (area and TPED) and to determine covariates associated 
with progression.
Results
Although on average Dupuytren disease was progressive in most fingers with 
regard to area (yearly increase ranging between 0.18 – 0.43 cm2) and TPED (yearly 
increase ranging between -0.20 – 2.61⁰), substantial numbers of  participants did not 
experience progression (area: 2.4 – 26.2%, TPED: 1.8 – 65.8%). There were only 
two covariates that were strongly associated with disease progression, namely the 
presence of  Ledderhose disease (area) and hospital population (TPED).
Conclusions
On the long-term, Dupuytren disease is progressive with regard to both area 
and TPED, but the increase in TPED is less pronounced. Ledderhose disease 
and population were covariates associated with progression. The majority of  the 
clinical and anamnestic factors were not (consistently) associated with progression, 
suggesting that such factors have limited importance when predicting disease course.
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INTRODUCTION
From a clinical point of  view, it is often thought that Dupuytren disease is 
strongly progressive. This might be explained by the fact that a hospital population 
usually consists of  patients with a more severe form of  the disease. In the general 
population, the majority of  cases have only a mild form of  the disease, in which 
only nodules are present.1 In such cases, it is probable that patients will not seek 
medical advice, since they have no complaints (yet). It might even be that they are 
unaware of  having a mild form of  Dupuytren disease. As such, it is likely that 
the hospital population is different from the general Dupuytren population. This 
assumption is further supported by the finding that there are also cases in which 
the disease is stable, or even in regression.2 Precise knowledge about the disease 
course is important to gain insight in the development of  the disease, to provide 
evidence-based patient information, and to facilitate the timing of  treatment. More 
importantly, it might be possible to identify factors that predict disease progression. 
There are a few studies in which the disease course was determined.2-5 However, 
in two of  these studies only two measurements were done.2,3 In this way, it is only 
possible to determine whether a change over time has taken place, but it provides 
no information about the exact course of  the disease. A third study described the 
results of  surgical treatment compared with no treatment, with a follow-up of  5.5 
years.4 Data of  the untreated controls can be considered as results on the natural 
disease course. Unfortunately, the sample size in this study was very small (47 
hands were included in control group, unknown to how many participants they 
belong) and no statistical analyses have been done to describe the disease course. 
This limits the interpretability of  the results. A fourth study is a prospective cohort 
study, in which progression over 1.5 years is clustered in groups of  similar disease 
course profiles.5 The short-term results of  this study showed that Dupuytren disease 
was stable in the majority of  the cases, but some experienced progression or even 
regression. Although a strong association was found between Tubiana stage at 
inclusion and change in disease extent, no other risk factors for disease progression 
were identified. 
In the current paper, the long-term results of  this prospective cohort study are 
presented. The following research questions are addressed: 1) What is the average 
and individual long-term course of  Dupuytren disease, and 2) What factors are 
associated with disease course? 
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METHODS
Design 
The design was a longitudinal prospective cohort study, in which measurements 
took place between June 2012 and January 2017 with an interval of  6 months. 
So, the follow-up period was 4.5 years and 10 measurements per participant were 
gathered in total. 
Participants
A total of  452 adult patients who had primary (i.e. untreated) Dupuytren disease 
in one or both hands, were asked for participation. The participants were recruited 
from two sources: 1) from a random sample, stratified on age, of  the general elderly 
population of  the city of  Groningen who were included in a previous study of  our 
research group,1 and 2) from Dupuytren patients who visited the outpatient clinic of  
the department of  Plastic Surgery for a consult on Dupuytren disease. A sample size 
calculation was not possible, since no data is available from comparable studies on 
long-term disease course. We estimated that after 5 years, data of  200 participants 
would be sufficient for statistical analyses. Taking drop-out into account, we aimed 
to include at least 250 participants.
This study was reviewed and approved by the institutional ethics committee, and 
all participants gave written informed consent.
Outcome measures
The primary outcome measures were disease extent and severity of  contracture. 
Disease extent was determined by physical examination of  the hands, in which 
the nodules and cords were marked with a skin pencil. We used the surface area 
of  nodules and cords measured with a tumorimeter, to quantify disease extent (see 
Chapter 5).6 The area of  nodules and cords in the same ray were summed to form a 
total area per finger. Contracture severity was determined by measuring the passive 
extension deficit (i.e. the flexion contracture) of  each finger joint, using a goniometer. 
These extension deficits were summed to form the total passive extension deficit 
(TPED) per finger. TPED was not measured in the thumb, as Dupuytren cords in 
the thumb rarely lead to functional restraints. Contractures of  cords in the first web 
space can lead to functional problems, but are not captured by measuring TPED.
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We collected information on sex and age, and during all follow-up measurements 
we interviewed the participants about possible risk factors for Dupuytren disease 
progression, such as (past) exposure to vibration or heavy manual work during 
occupational or leisure activities, smoking and drinking habits, hand injuries, 
abnormal scarring, and familial occurrence of  Dupuytren disease. Further, we 
asked the participants about the presence of  diabetes mellitus, liver disease, epilepsy, 
Ledderhose disease, Peyronie disease, and general health. In case of  doubt about 
the presence of  Ledderhose disease, the feet were examined. The hands were also 
examined for presence of  knuckle pads. 
Procedures
Data of  the first 1.5 years were gathered by the second author, while the first author 
gathered data during further measurements. An inter-observer agreement study was 
done to ensure reliability of  the measurements (Chapter 5).6 All measurements were 
done using exactly the same instruments.
Every 6 months, the participants visited the outpatient clinic of  the Department 
of  Plastic Surgery for this study. In case the participant was not able to visit the 
hospital, e.g. due to injuries or decreased health, the examiner visited the participant 
at home if  possible. During the course of  the study, a few participants refused to 
visit the hospital every 6 months. To prevent drop-out, they were asked to continue 
participation with a yearly visit. 
Some participants received treatment during the course of  the study. Data 
collection continued, but the data of  the treated hand was excluded from the current 
analysis. Data from participants who were treated at both hands during the course 
of  the study was also excluded from the current analysis. 
Statistical Analysis
Characteristics of  the participants were described using frequencies and percentages 
for count data, and with means and standard deviations for normally distributed 
continuous variables. For data that was not normally distributed, medians and 
interquartile ranges (IQR) were used.
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The statistical analysis was applied to the surface area of  nodules and cords, and 
to TPED separately. Furthermore, for each outcome the analysis was conducted per 
finger and it contained several steps. 
The first step was to fit subject-specific time profiles for each individual using 
a mixed-effects model. The time profile was taken linear. In case the finger was 
affected by Dupuytren disease for the full follow-up period, the intercept and slope 
of  the time profile were taken bivariate normally distributed, but when Dupuytren 
disease started somewhere during follow-up (thus after the start of  the study), the 
intercept was taken zero until the moment when Dupuytren disease was detected, 
and the slope was considered random (for extensive explanation, see Appendix 7.1). 
The six parameter estimates of  this model (parameter estimate for intercept and 
slope, three variance components, and one correlation coefficient) were reported, 
as well as the R2 value that indicates how much variability in the observations is 
explained by the model.
The second step tried to select relevant covariates one by one before a more 
extensive model was possibly fitted. The same linear fixed-effects model was used 
as in the first step, but it was extended with one covariate. The disease progression 
(slope) could depend on the covariate, but not the baseline severity (intercept) since 
we were only interested in how progression would be influenced. This model was 
compared with the model in the first step using a likelihood ratio test at significance 
level alpha = 0.06 to test whether the covariate affected the area and TPED. If  
three or more fingers showed a significant likelihood ratio test (from the 8 fingers 
without the thumb), the covariate was selected for further analysis. Note that the 
probability of  selecting three (or more) significances, when the covariate would not 
influence the disease progression, is equal to an overall type I error rate of  0.01. The 
covariates that were investigated one-by-one are sex, baseline age, smoking (never/
ever), alcohol (never/ever), past hand injury (yes/no), manual labor (yes/no), 
manual hobbies (yes/no), Peyronie disease (yes/no), Ledderhose disease (yes/no), 
knuckle pads (yes/no), scars (yes/no), diabetes (yes/no), epilepsy (yes/no), liver 
disease (yes/no), first degree relatives with Dupuytren disease (yes/no), dominance 
(left/other), population (hospital/general (nonhospital)). 
In the third step, the covariates that were selected in the second step were then put 
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in the linear mixed-effects model as in the second step, but now with all variables 
simultaneously. This was done only for progression (slope). The parameter estimates, 
their 95% confidence intervals, and p-values are being reported. 
The selected model could easily handle missing values when they would be 
‘missing at random’. We decided not to impute missing data.
In all analysis we used maximum likelihood estimation. The statistical analysis 
of  the linear mixed effects model was conducted with procedure NLMIXED of  
SAS institute, version 9.4. The trust region method was applied for the numerical 
method to maximize the likelihood with a maximum of  25 quadrature points. 
RESULTS
Of the 452 eligible patients, 258 patients with primary Dupuytren disease in 
at least one hand, decided to participate. The number of  participants and cases 
with available data during each measurement time are not equal (Table 1), since 
some participants were not able to attend each measurement time. The number 
of  participants with available data is lower at T7-T9, as not all participants were 
included at the same time. From the 258 participants, 36 withdrew their consent 
during follow-up, 20 participants were excluded from the analyses due to bilateral 
treatment, 7 participants passed away, 6 were lost to follow-up, 5 were excluded 
since no Dupuytren disease was observed anymore in the untreated hand, and 2 
were excluded by the researcher because they had cognitive decline making further 
participation unethical, leaving 182 participants at T9. Missing values in the active 
participants were scarce (< 3% from 16,340 observations). 
The sample consisted of  163 men and 95 women, with a mean age of  66.4 
Table 1. The number of  participants and cases with available data presented for each measurement 
time.
T0 T1 T2 T3 T4 T5 T6 T7 T8 T9
Follow up (yrs) Start 0.5 1 1.5 2 2.5 3 3.5 4 4.5
Participants (n) 258 249 242 228 215 203 198 193 185 182
Available data (n) 258 244 237 223 202 182 185 172 168 155
N: number of  subjects; T: measurement time. 
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(SD 10.4) at inclusion, with a range of  26 to 89 years. Of  the 258 participants, 111 
were recruited from the general population, and 147 from the hospital population. 
Those who could recall the age of  onset (n = 198), reported a mean age of  onset of  
54.6 (SD 11.8) years. 
The majority of  the participants were smokers or former smokers, and for those, 
a median of  11 (IQR: 2 – 25) pack years was found. Among the participants who 
consumed alcohol, a median of  7 (IQR: 3 – 13) glasses per week was reported. 
Further details on the characteristics of  the participants are presented in Table 2. 
The median time of  follow-up was 52 months (IQR: 31 – 53).
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Table 2. Characteristics of  the cohort.
N (%) N missing (%)
Personal factors





1st degree relative with DD 119 (46.1) 1 (0.4)
Diabetes 33 (12.8) 0 (0.0)
Liver disease 9 (3.5) 0 (0.0)
Epilepsy 3 (1.2) 0 (0.0)
Ledderhose disease 35 (13.6) 0 (0.0)
Peyronie disease (only in men) 15 (9.2) 0 (0.0)






Heavy manual work 115 (44.6) 0 (0.0)
Hobbies with heavy manual work 114 (44.2) 43 (16.7)
Exposure to vibration 174 (67.4) 6 (2.3)








Hand injury 184 (71.3) 0 (0.0)
N: number; DD: Dupuytren disease
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Natural course of  Dupuytren disease – Area of  nodules and cords
The parameter estimates of  the linear mixed-effects model that does not yet include 
any of  the covariates, are presented in Table 3 for area. The intercepts indicate 
the average area (disease extent) at the start of  the study presented per finger, for 
all fingers affected with Dupuytren disease at a certain moment during the study. 
The parameter estimates of  slope indicate the average increase in area (cm2) per 
year. The results show that on average, the area of  nodules and cords increases 
significantly over time, indicated by positive parameter estimates for slope. So, for 
example, the area of  nodules and cords in the right index finger increases yearly with 
0.33 cm2 on average. This appears to be only a small increase, but a round shaped 
nodule with a diameter of  0.65 cm has a surface area of  0.33 cm2. Furthermore, this 
concerns an increase per year, which means that in the right index finger, the surface 
area has increased on average with 1.49 cm2 during the 4.5 year follow-up. This is 
equivalent to the formation of  a new cord with a length of  3.0 cm and width of  0.50 
cm. There were no large differences in increase in area between the left and right 
hand or between left and right fingers. The variance parameters show that there is 
a substantial amount of  variation between participants, both in area at start of  the 
study (variance intercept) and disease progression (variance slope). The area at start 
of  the study does not seem to be strongly correlated to progression (correlation), 
except for the right thumb and left ring finger. There still seems to be a reasonable 
amount of  unexplained variation in the data (variance residuals), but this is not 
really true since the model fit (R2) ranged between 81.5 and 94.7%. 
Natural course of  Dupuytren disease – TPED
The parameter estimates in Table 4 can be interpreted in the same way as described 
for area in Table 3. The results show that overall, the TPED at the start of  the study 
(intercept) was low, but increased over time. However, a decrease of  TPED was also 
found in the right index finger, although statistical significance was not reached in 
the index fingers. The yearly average increases are small, ranging between -0.2 and 
2.6°, while the variance of  slope is large in the left ring and little finger. The model 
fit (R2) ranged between 83.3 and 95.4%.
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As we mentioned earlier, each individual had its own disease course profile. In 
Table 5 we have provided the percentage of  participants who did not have a disease 
progression. These results are calculated for each finger and outcome separately. 
The percentage participants having regression varies between hands and fingers, 
although in the left middle fingers, almost a quarter of  the participants experienced 
disease regression, measured as area. With respect to TPED, even 65% of  the 
participants experienced disease regression in the right index finger. In the right 
thumb (area) and left ring finger (TPED), low percentages of  regression were found.
Table 5. Percentage of  participants having regression, presented  for each finger and outcome 
separately.
Area TPED




Thumb 85 2.35 NA
Index 49 6.12 65.3
Middle 122 26.2 8.20
Ring 164 14.6 2.44




Thumb 96 8.33 NA
Index 39 2.56 7.69
Middle 134 25.4 5.22
Ring 169 14.2 1.78
Little 141 13.5 4.26
n: number; TPED: total passive extension deficit; NA: not applicable. 
Factors associated with progression 
In Table 6 we have listed the results from the selection of  the single covariates 
influencing the disease progression (step 2 of  the analyses). The reported ‘Area’ 
in the table indicates that the covariate has a significant influence on the outcome 
variable area of  nodules and cords. The reported ‘TPED’ indicates that the covariate 
has a significant influence on the outcome variable TPED. So, for example, the 
covariate sex had a significant influence on area in the right index finger, and on 
TPED in the right ring finger. It is important to note that such findings might be 
due to chance. This is why we selected covariates for the multivariate model (step 
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Table 6. Selection of  single covariates with an effect on disease progression.
Left Right
Index Middle Ring Little Index Middle Ring Little
Male sex Area TPED






Hand injury Area 
TPED
TPED
Heavy manual work TPED Area Area




Peyronie disease TPED TPED 
Ledderhose disease Area Area Area Area 
TPED 
TPED
Knuckle pads Area TPED
Abnormal scarring Area TPED
Diabetes
Epilepsy Area
Liver disease TPED TPED 
First degree relatives 
with DD
Area
Right dominance TPED TPED
Hospital population TPED TPED TPED Area 
TPED
TPED: total passive extension deficit; DD: Dupuytren disease. 
3 of  the analyses), only when the covariate was significantly associated with the 
outcome in at least three fingers. This was the case for Ledderhose disease, which 
seems to influence disease progression in four fingers on the outcome area. The 
same was found for population, which seems to influence disease progression in 
four fingers on the outcome TPED. 
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In Table 7, the parameter estimates of  the effect of  Ledderhose disease on 
progression of  area (slope) are presented. Only the fingers for which Ledderhose 
disease was significant were reported. The second column of  the table (‘Constant’) 
presents the slope of  participants without Ledderhose disease. The positive parameter 
estimates in this column indicate that participants without Ledderhose disease had 
disease progression. The fourth column of  the table (‘Ledderhose disease’) presents 
the influence of  Ledderhose disease on the slope of  area, or in other words, the 
influence of  having Ledderhose disease on the disease course. To obtain the slope 
of  participants with Ledderhose disease, this parameter estimate has to be added to 
the parameter estimate reported in the column ‘Constant’. Note that the parameter 
estimate of  Ledderhose disease in the left index finger is negative, indicating that 
participants with Ledderhose disease have less rapid disease progression in the 
left index finger, than those not suffering from Ledderhose disease. In the other 
fingers, participants with Ledderhose disease had more rapid progression than 
those without, as indicated by the positive parameter estimates for ‘Constant’ and 
‘Ledderhose disease’. 
Table 7. Effect of  Ledderhose disease on disease progression measured as area.
AREA Disease progression
Constant p-value Ledderhose disease a p-value
Left index
0.56 

























a Reference = no Ledderhose disease.
In Table 8, the parameter estimates of  the effect of  population on progression of  
TPED (slope) are presented. Only the fingers for which population was significant 
were reported. The interpretation of  the parameter estimates is similar as explained 
above. The parameter estimates of  population for progression of  TPED are all 
positive, indicating that participants from the hospital population have more rapid 
disease progression than participants from the general population. 
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Table 8. Effect of  population on disease progression measured as TPED.  
TPED Disease progression




























a Reference = general population.
TPED: total passive extension deficit.
 
DISCUSSION
This study shows that overall, Dupuytren disease is progressive on the long term, 
with respect to disease extent (area). Progression in contracture severity (TPED) 
is also present, but less pronounced than for area. However, there were also cases 
that experienced disease regression in both area and TPED, since heterogeneity 
across participants was large. Furthermore, we demonstrated that Ledderhose 
disease and population are factors associated with progression, although we could 
not demonstrate this in all fingers. This study is the first step towards a progression 
prediction model, that might be used in clinical practice to quantify risk of  
progression.
There are no other studies known that describe disease course of  Dupuytren disease 
based on prospectively gathered longitudinal data. The prospective nature of  this 
study limits the chance of  missing values, which is often a problem in retrospective 
database or patient file studies. Additionally, the follow-up measurements were 
done every 6 months, enabling a reliable estimation of  the exact disease course 
profile. Our models were able to explain 81.5 to 94.7% of  the variance for area, and 
83.3 to 95.4% for TPED.
Another strength is that we used area of  nodules and cords to measure disease 
extent. Disease extent is a parameter that can reflect disease progression apart 
from contracture severity measured as TPED. Although previous studies recorded 
outcomes such as “progression to bilateral disease” or “progression from nodules 
to cords”, or defined progression as a change in disease stage, none of  these studies 
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quantified the disease extent.2-4 By using area as outcome measure, we were able to 
follow the disease course also in participants with mild disease, without contractures.
Although measurement bias might have occurred when data collection was taken 
over by another observer, we performed an agreement study to determine whether 
the analyses required adjustment for this (Chapter 5).6 Overall, high intraclass 
correlations were obtained, except for measurements of  TPED in the left middle 
finger. So, it is unlikely that measurement bias played a large role in determining 
area and TPED. However, recall bias might have occurred in determining the risk 
factors, since this was gathered using an interview. To limit the influence of  recall 
bias we interviewed the participants during each visit. Means and medians were 
used in the analyses, increasing the reliability of  our measurements. Furthermore, 
changes in lifestyle or health status, that might influence the disease course, were 
identified early because of  these repeated interviews. Despite this, it is possible that 
Peyronie disease has been underreported in our study, as physical examination of  
the genital area was not part of  the data collection. 
Drop-outs may form a problem in prospective studies, especially in longitudinal 
cohort studies with frequent follow-up measurements. In our study, this might have 
introduced selection bias, as it is possible that participants with mild Dupuytren 
disease were less motivated to continue long-term participation. As described in 
the methods, we had several strategies to prevent drop-out, but still a significant 
number of  participants (n = 36) withdrew their consent during the study. However, 
the ratio of  withdrawers in the general and hospital populations was comparable to 
the inclusion ratio (resp. 1:1.2 and 1:1.3), so selection bias seems unlikely. It can be 
argued to increase the follow-up interval of  6 months to, for instance, 12 months for 
continuation of  this study, limiting the burden for the participants and to prevent 
further drop-out.
Our results, showing that Dupuytren disease is progressive in hospital patients 
with respect to TPED, are in line with the clinical point of  view and in line with 
some previous studies.2,3 
We were surprised by the finding that TPED only shows very small increases 
(or even a decrease, although not statistically significant) over time. However, it 
should be noted that the number of  participants having flexion contractures during 
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the study, was limited. Furthermore, we used a linear time profile to estimate the 
course of  TPED, and the reported estimates display the average increase over 4.5 
years. Clinical experience shows that TPED is characterized by rapid increases, in 
which contractures can occur within a few weeks to months. This seems to be in 
conflict with our findings, but this is not necessarily the case, since the heterogeneity 
between participants was substantial. Although we thought of  using other profiles 
than a linear time profile, such as an exponential time profile, visual inspection of  
the data did not show the necessity of  using exponential models. Also, the fits of  our 
models were high, indicating that the selected models do describe the data well, and 
limited improvement in model fit is possible with other time profiles. This might be 
explained by the fact that the start of  an exponential growth curve approximates 
the linear relationship like we modeled it (Figure 1). Furthermore, the hands of  
many participants having rapid increase in TPED were excluded from the analysis 
as they received treatment to correct the contractures. So, in these cases, exponential 
growth could not be determined properly.
Figure 1. Representation of  a linear model (that we used in our data-analyses) approximating an 
exponential model. The lines represent fictional data, only used as an example. At the time the 
total passive extension deficit (TPED) reached a certain threshold, the participant was treated and 
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We also demonstrated that the presence of  Ledderhose disease is associated with 
more rapid progression in area, and that participants from a hospital population 
have more rapid progression in TPED. So, there were only two covariates providing 
consistent results in multiple fingers. 
From these results, it seems that the hospital and general populations are not 
the same. The question rises what exactly defines this difference between the 
two populations. When comparing these two populations on characteristics that 
we measured, there were some significant differences between the two groups 
(Appendix 7.2), although the covariates in which they differed were not identified 
as predictor, except for Ledderhose disease. It is possible that genetics may be part 
of  the explanation, as patients having family members suffering from Dupuytren 
disease will probably be more aware of  this disease, recognize it earlier and visit the 
hospital in an early stage. Such patients were included in our hospital population. 
However, having an affected first degree relative did not appear to influence 
progression in any of  the outcomes. It might also be that the true number of  affected 
relatives is underreported in the general population, as many participants answered 
the question “Does Dupuytren disease run in your family?” with “Not as far as I 
know”. The fact that the majority of  the participants did not have parents who are 
alive, might also contribute to underreporting. Future analyses including genetic 
information might provide insight in this assumption.
The interim analyses of  this study could not identify an overall time profile for 
short-term disease course.5 From the current results, it is clear that Dupuytren 
disease is progressive. Furthermore, in the interim analyses no covariates associated 
with disease progression were found, except for disease extent at baseline.5 In the 
current analyses, we found two factors that were associated with progression. These 
differences in results can be explained by the longer follow-up time. In the current 
study, 4.5 years of  data were used instead of  1.5 year follow-up data. It is likely that 
during the interim-analysis, the change over time was too small to be discriminated 
from measurement error. By continuing follow-up measurements (and consequently, 
increasing the amount of  data), estimations of  effects have become more precise. 
Furthermore, we used another approach for the statistical analyses, as the increased 
amount of  data made the data-analysis much more complex. Especially the fact that 
many participants developed Dupuytren disease in a finger that was unaffected at 
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inclusion, is something that currently cannot be modeled with existing latent class 
models. Additionally, latent class modeling is not directly suitable to quantify the 
influence of  factors associated with progression.
Nevertheless, it needs to be noted that the number of  covariates that were associated 
with disease course, is very limited. This suggests that clinical variables like we 
collected do not seem to be important for predicting disease course. Furthermore, 
variables predicting disease extension or recurrence that were identified by 
previous studies, such as family history and male sex, were not associated with 
disease progression in our study.7-9 As we cannot explain this discrepancy, apart 
from recall bias with respect to family history as explained before, new prospective 
studies should be done to evaluate this. The authors of  a previous retrospective 
database study claim to have identified predictors for progression, namely bilateral 
disease, radial involvement, and little finger surgery.7 We did not include these in 
our analyses, since it can be questioned whether these features are predictors for 
progression, or rather a consequence of  progression. In our opinion, the suggested 
causal relation is the other way around: due to progression, patients are more likely 
to have bilateral disease, radial involvement and surgery in the little finger. 
CONCLUSION
Due to the prospective nature of  this study and the well-fitting statistical models, 
this study provides reliable conclusions about long-term natural disease course of  
Dupuytren disease. Overall, Dupuytren disease is progressive, but the speed of  
progression varies between participants from the hospital and general population, 
and between those with and without Ledderhose disease. An important finding is 
that the majority of  the clinical and anamnestic characteristics that we collected 
were not associated with disease progression. This suggests that we should shift 
focus from clinical and anamnestic predictors to other predictors, such as genetic 
or cell biological factors. Since whole genome sequencing has become cheaper, 
it is relevant to evaluate whether patient-specific genetic risk profiles can predict 
progression. This will lay the foundations for personalized medicine, in which the 
treatment policy can be adapted to the specific risk and needs of  a patient.
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Appendix 7.1. Explanation of  mixed-effects models
The mixed-effects models that we used in our analyses, can be considered as an 
extension of  linear regression analysis, with a random intercept and/or a random 
slope. In other words, it is linear regression analysis in which the intercept and 
slope of  the line can vary between participants (Figure A). This means that for each 
individual participant a separate line is fit. In this way, the model is able to handle 
the data clustering that occurs as consequence of  the repeated measures within par-
ticipants. It is necessary to take this into account, as data that are derived within 
participants, such as repeated measures, cannot be considered as independent ob-
servations.
In our analyses, the intercept represents the area or TPED at start of  the study 
(area and TPED were analyzed separately). The slope tells us something about dis-
ease course. A negative slope, which means that the line is descending, indicates 
regression, while a positive slope indicates progression. A slope that equals zero 
indicates no change over time, which is stability. In mixed-effects models, the inter-
cept is usually taken random, and sometimes the slope is taken random too. How-
ever, in our dataset, there were many participants who did not have contractures in 
a finger until a certain moment in time. So, for these participants, we knew that the 
intercept was zero, until the moment that contracture occurred. In these cases, only 
the slope was considered random, while the intercept was set at zero until contrac-
ture occurred (Figure A, red solid line). The same principle was used for area: when 
Dupuytren disease occurred in a finger after start of  the study, the intercept was 
taken zero until the moment that Dupuytren tissue was found in that finger. 
158
4.5-year results of  a prospective cohort study on disease course of  primary Dupuytren disease
 
Figure A. Graphical representation of  the principles behind mixed-effects 
models as used in our analyses. Each line represents the disease course of  total passive 
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